Human airway trypsin-like protease stimulates protease activated receptors and interactions of these receptors

M. MIKI (Toyonaka, Japan), S. Yasuoka (Tokushima, Japan), R. Tsutsumi (Tokushima, Japan), Y. Takeuchi (Toyonaka, Japan), K. Miki (Toyonaka, Japan), S. Kitada (Toyonaka, Japan)

Source: International Congress 2019 – Immunopathological mechanisms of lung disease
Session: Immunopathological mechanisms of lung disease
Session type: Thematic Poster
Number: 4090
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. MIKI (Toyonaka, Japan), S. Yasuoka (Tokushima, Japan), R. Tsutsumi (Tokushima, Japan), Y. Takeuchi (Toyonaka, Japan), K. Miki (Toyonaka, Japan), S. Kitada (Toyonaka, Japan). Human airway trypsin-like protease stimulates protease activated receptors and interactions of these receptors. 4090

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Analysis of signal transduction pathways involved in proteinase activated receptor-2 (PAR-2) stimulated mucus secretion in human tracheal gland cell culture
Source: Annual Congress 2008 - Airway cell biology
Year: 2008

Protease activated receptor 2 (PAR2) antagonism reduces pro-inflammatory cytokine production in bronchial epithelial cells
Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies
Year: 2020


Activity of ENaC-activating serine proteases in human alveolar epithelial cells
Source: Virtual Congress 2020 – Respiratory homeostasis and structural changes in disease
Year: 2020


MMP-12 activates protease activated receptor (PAR)-1, upregulates placenta growth factor and leads to pulmonary emphysema
Source: International Congress 2018 – COPD: novel pathological mechanisms in the airway epithelium
Year: 2018

The influence of protease activated receptors on the secretome of respiratory epithelial cells: a proteomic approach
Source: Annual Congress 2007 - Mechanisms of inflammation in asthma and rhinitis - from cell cultures to patients
Year: 2007


Protease activated receptor-1 (PAR-1) stimulation leads to αvβ6 integrin mediated TGFβ activation via rho kinase
Source: Eur Respir J 2005; 26: Suppl. 49, 238s
Year: 2005

SerpinB1 in cystic fibrosis airway fluids: quantity, molecular form and mechanism of elastase inhibition
Source: Eur Respir J 2011; 37: 1083-1090
Year: 2011



Inhibition of eosinophil migration by montelukast, a cysteinyl leukotriene receptor antagonist, through down regulation of plasmin activity
Source: Eur Respir J 2004; 24: Suppl. 48, 36s
Year: 2004

Human Airway Trypsin-like protease exerts potent anti-fibrotic role in vivo.
Source: International Congress 2017 – Rare diseases
Year: 2017

Role of purinergic receptors in the activation of human airway smooth muscle cells by the antimicrobial peptide LL-37
Source: Eur Respir J 2006; 28: Suppl. 50, 339s
Year: 2006

Role of thrombin and thrombin receptor in the activation of human bronchial epithelial cells during airway inflammation
Source: Eur Respir J 2007; 30: Suppl. 51, 523s
Year: 2007

Role of purinergic receptors in the activation of human airway smooth muscle cells by the antimicrobial peptide LL-37
Source: Eur Respir Rev 2006; 15: 182-184
Year: 2006



Human airway trypsin-like protease stimulates differentiation of fibroblasts to myofibroblasts in human bronchial fibroblasts in vitro
Source: International Congress 2018 – Identification of therapeutic targets for asthma
Year: 2018


A functional variant of secretory leukocyte protease inhibitor (SLPI) with improved anti-inflammatory activity against pulmonary infection
Source: Lung Science Conference 2015
Year: 2015

Stimulation of P2 purinergic receptors induces the release of eosinophil cationic protein and interleukin-8 from human eosinophils
Source: Eur Respir J 2003; 22: Suppl. 45, 548s
Year: 2003

LSC Abstract – A functional variant of secretory leukocyte protease inhibitor (SLPI) with improved anti-inflammatory activity against pulmonary infection
Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects
Year: 2015

Effect of chronic stimulation of protease activating receptor-2 in human bronchial smooth muscle cells
Source: Annual Congress 2010 - Mechanisms and modulation of allergic inflammation in the lung
Year: 2010

Secretory leucoprotease inhibitor (SLPI) inhibits IL-8 expression induced by double-stranded RNA in airway epithelial cells
Source: Annual Congress 2008 - Airway cell biology
Year: 2008


Effect of activated protein C on the thrombin signalling pathway in alveolar epithelial cells
Source: Annual Congress 2009 - Acute lung injury: biological mechanisms
Year: 2009